(Q28269915)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Gary E Landreth

series ordinal

2

2 references

https://doi.org/10.1016%2FS1470-2045%2804%2901509-8

25 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Michael T Heneka

series ordinal

3

2 references

https://doi.org/10.1016%2FS1470-2045%2804%2901509-8

25 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231248%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

30 December 2019

published in

2 references

https://doi.org/10.1016%2FS1470-2045%2804%2901509-8

25 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

5

2 references

https://doi.org/10.1016%2FS1470-2045%2804%2901509-8

25 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

7

2 references

https://doi.org/10.1016%2FS1470-2045%2804%2901509-8

25 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

419-429

2 references

https://doi.org/10.1016%2FS1470-2045%2804%2901509-8

25 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231248%20AND%20SRC:MED&resulttype=core&format=json

Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

How many nuclear hormone receptors are there in the human genome?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Activation of PPARgamma coactivator-1 through transcription factor docking

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Emerging roles of PPARs in inflammation and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Terminal differentiation of human breast cancer through PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

A phase II trial with rosiglitazone in liposarcoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

PPARgamma inhibits the expression of c-MET in human gastric cancer cells through the suppression of Ets.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Expression of peroxisome proliferator activated receptor mRNA in normal and tumorigenic rodent mammary glands

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Effect of fatty acid supplementation on growth and differentiation of human IMR-32 neuroblastoma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Expression of PPARgamma and its ligand-dependent growth inhibition in human brain tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901509-8

7 January 2021

10.1016/S1470-2045(04)01509-8

Identifiers

DOI

3 references

https://doi.org/10.1016%2FS1470-2045%2804%2901509-8

25 March 2017

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231248%20AND%20SRC:MED&resulttype=core&format=json

release_xvj3nx2btndife63462cnzafxm

30 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xvj3nx2btndife63462cnzafxm

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017